Literature DB >> 3298022

Modulation of polyclonal activation by plasma fibronectin and fibronectin fragments.

R Dziarski.   

Abstract

Modulation of activation of polyclonal IgM, IgG and IgM anti-DNA antibodies by plasma fibronectin (Fn) was studied because in some autoimmune diseases there appears to be a correlation between the increased level of Fn in the affected tissues and increased polyclonal B-cell activation. Fn caused a dose-dependent polyclonal activation of IgM, IgG and IgM anti-DNA antibody-secreting cells in cultures of mouse splenocytes. Fn significantly inhibited the generation of polyclonal antibodies by Fn-binding stimulants and did not significantly change the generation of polyclonal antibodies by the stimulants that do not bind Fn. Plasmin or trypsin digestion of Fn abolished both the polyclonal activating properties of Fn and the inhibitory effects of Fn that were selective for the Fn-binding polyclonal activators. Digestion of Fn with trypsin also generated immunosuppressive Fn fragments that inhibited polyclonal activation by both Fn-binding and non-binding bacteria. Under our culture conditions Fn or Fn digests were not mitogenic and had no effect on the mitogenicity of Fn-binding and non-binding stimulants. These results indicate that Fn can act as a polyclonal activator and that it can also modulate lymphocyte activation induced by other activators.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3298022      PMCID: PMC1453372     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  25 in total

1.  Fibronectin and its role in connective tissue diseases.

Authors:  I Clemmensen
Journal:  Eur J Clin Invest       Date:  1981-06       Impact factor: 4.686

2.  Preferential induction of autoantibody secretion in polyclonal activation by peptidoglycan and lipopolysaccharide. II. In vivo studies.

Authors:  R Dziarski
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

3.  A macrophage surface component related to fibronectin is involved in the response to migration inhibitory factor.

Authors:  H G Remold; J E Shaw; J R David
Journal:  Cell Immunol       Date:  1981-02       Impact factor: 4.868

4.  Purification of fibronectin from human plasma by affinity chromatography under non-denaturing conditions.

Authors:  M Vuento; A Vaheri
Journal:  Biochem J       Date:  1979-11-01       Impact factor: 3.857

5.  Detection and quantitation of fibronectin in synovial fluid from patients with rheumatic disease.

Authors:  S Carsons; M W Mosesson; H S Diamond
Journal:  Arthritis Rheum       Date:  1981-10

6.  Fibronectin enhances in vitro monocyte-macrophage-mediated tumoricidal activity.

Authors:  R T Perri; N E Kay; J McCarthy; R L Vessella; H S Jacob; L T Furcht
Journal:  Blood       Date:  1982-08       Impact factor: 22.113

7.  Plasma fibronectin in systemic lupus erythematosus: relationship to clinical activity, DNA binding and acute phase proteins.

Authors:  S Carsons; D Parenti; B B Lavietes; H S Diamond; A Singer; M Boxer
Journal:  J Rheumatol       Date:  1985-12       Impact factor: 4.666

8.  Fibronectin fragment(s) are chemotactic for human peripheral blood monocytes.

Authors:  D A Norris; R A Clark; L M Swigart; J C Huff; W L Weston; S E Howell
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

9.  Significance of fibronectin in rheumatoid arthritis and osteoarthrosis.

Authors:  D L Scott; A C Wainwright; K W Walton; N Williamson
Journal:  Ann Rheum Dis       Date:  1981-04       Impact factor: 19.103

10.  Augmentation of human monocyte opsonin-independent phagocytosis by fragments of human plasma fibronectin.

Authors:  J K Czop; J L Kadish; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

View more
  1 in total

1.  Fibronectin in multiple sclerosis lesions.

Authors:  R A Sobel; M E Mitchell
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.